AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/101
A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA
Authors: DENARDO GL ODONNELL RT OLDHAM RK DENARDO SJ
Citation: Gl. Denardo et al., A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 213-223
LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY
Authors: DENARDO GL DENARDO SJ LAMBORN KR GOLDSTEIN DS LEVY NB LEWIS JP OGRADY LF RAVENTOS A KROGER LA MACEY DJ MCGAHAN JP MILLS SL SHEN S
Citation: Gl. Denardo et al., LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 239-254
PROLONGED SURVIVAL ASSOCIATED WITH IMMUNE-RESPONSE IN A PATIENT TREATED WITH LYM-1 MOUSE MONOCLONAL-ANTIBODY
Authors: DENARDO SJ KROGER LA MACKENZIE MR MIRICK GR SHEN S DENARDO GL
Citation: Sj. Denardo et al., PROLONGED SURVIVAL ASSOCIATED WITH IMMUNE-RESPONSE IN A PATIENT TREATED WITH LYM-1 MOUSE MONOCLONAL-ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-12
RADIOIMMUNOTHERAPY FOR KAPOSIS-SARCOMA - PRECLINICAL EVALUATION OF THE L6 MONOCLONAL-ANTIBODY
Authors: LEIGH BR HONG AM ODONNELL RT BURKE P HOWELL L DENARDO GL DENARDO SJ
Citation: Br. Leigh et al., RADIOIMMUNOTHERAPY FOR KAPOSIS-SARCOMA - PRECLINICAL EVALUATION OF THE L6 MONOCLONAL-ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 13-13
MILESTONES IN THE DEVELOPMENT OF LYM-1 RADIOIMMUNOTHERAPY
Authors: DENARDO GL DENARDO SJ KROGER LA GOLDSTEIN DS LAMBORN KR SHEN S ODONNELL RT
Citation: Gl. Denardo et al., MILESTONES IN THE DEVELOPMENT OF LYM-1 RADIOIMMUNOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 44-44
COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS
Authors: DENARDO GL KROGER LA MEARES CF RICHMAN CM SALAKO Q SHEN S LAMBORN KR PETERSON JJ MIERS LA ZHONG GR DENARDO SJ
Citation: Gl. Denardo et al., COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS, Clinical cancer research, 4(10), 1998, pp. 2483-2490
MAXIMUM-TOLERATED DOSE, TOXICITY, AND EFFICACY OF I-131 LYM-1 ANTIBODY FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA
Authors: DENARDO GL DENARDO SJ GOLDSTEIN DS KROGER LA LAMBORN KR LEVY NB MCGAHAN JP SALAKO Q SHEN S LEWIS JP
Citation: Gl. Denardo et al., MAXIMUM-TOLERATED DOSE, TOXICITY, AND EFFICACY OF I-131 LYM-1 ANTIBODY FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(10), 1998, pp. 3246-3256
MEMORIAL AND EULOGY - GORTEN,RALPH,J, MD - 1927-1997
Authors: DENARDO GL DENARDO SJ
Citation: Gl. Denardo et Sj. Denardo, MEMORIAL AND EULOGY - GORTEN,RALPH,J, MD - 1927-1997, Clinical nuclear medicine, 23(6), 1998, pp. 402-403
QUANTIFICATION OF I-131 IN TUMORS USING A THRESHOLD BASED ON IMAGE-CONTRAST
Authors: DENARDO GL SHEN S DENARDO SJ LIAO SQ LAMBORN KR DENARDO DA YUAN A
Citation: Gl. Denardo et al., QUANTIFICATION OF I-131 IN TUMORS USING A THRESHOLD BASED ON IMAGE-CONTRAST, European journal of nuclear medicine, 25(5), 1998, pp. 497-502
NEW ANTI-CU-TETA AND ANTI-Y-DOTA MONOCLONAL-ANTIBODIES FOR POTENTIAL USE IN THE PRE-TARGETED DELIVERY OF RADIOPHARMACEUTICALS TO TUMOR
Authors: FENG X PAK RH KROGER LA MORAN JK DENARDO DG MEARES CF DENARDO GL DENARDO SJ
Citation: X. Feng et al., NEW ANTI-CU-TETA AND ANTI-Y-DOTA MONOCLONAL-ANTIBODIES FOR POTENTIAL USE IN THE PRE-TARGETED DELIVERY OF RADIOPHARMACEUTICALS TO TUMOR, Hybridoma, 17(2), 1998, pp. 125-132
L6 MONOCLONAL-ANTIBODY BINDS PROSTATE-CANCER
Authors: ODONNELL RT DENARDO SJ SHI XB MIRICK GR DENARDO GL KROGER LA MEYERS FJ
Citation: Rt. Odonnell et al., L6 MONOCLONAL-ANTIBODY BINDS PROSTATE-CANCER, The Prostate, 37(2), 1998, pp. 91-97
MAXIMUM TOLERATED DOSE OF CU-67-2IT-BAT-LYM-1 FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PILOT-STUDY
Authors: DENARDO GL DENARDO SJ KUKIS DL ODONNELL RT SHEN S GOLDSTEIN DS KROGER LA SALAKO Q DENARDO DA MIRICK GR MAUSNER LF SRIVASTAVA SC MEARES CF
Citation: Gl. Denardo et al., MAXIMUM TOLERATED DOSE OF CU-67-2IT-BAT-LYM-1 FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PILOT-STUDY, Anticancer research, 18(4B), 1998, pp. 2779-2788
A PRELIMINARY CELL-KINETICS MODEL OF THROMBOCYTOPENIA AFTER RADIOIMMUNOTHERAPY
Authors: SHEN S DENARDO GL JONES TD WILDER RB ODONNELL RT DENARDO SJ
Citation: S. Shen et al., A PRELIMINARY CELL-KINETICS MODEL OF THROMBOCYTOPENIA AFTER RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 39(7), 1998, pp. 1223-1229
FACTORS AFFECTING I-131 LYM-1 PHARMACOKINETICS AND RADIATION-DOSIMETRY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
Authors: DENARDO GL DENARDO SJ DENARDO DA SHEN S MIRICK GR MACEY DJ LAMBORN KR
Citation: Gl. Denardo et al., FACTORS AFFECTING I-131 LYM-1 PHARMACOKINETICS AND RADIATION-DOSIMETRY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), The Journal of nuclear medicine, 39(5), 1998, pp. 438-438
EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE
Authors: DENARDO SJ SHEN S KROGER LA MIERS LA RICHMAN CM KUKIS DL SALAKO Q MEARES CF DENARDO GL
Citation: Sj. Denardo et al., EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE, The Journal of nuclear medicine, 39(5), 1998, pp. 833-833
SPLENIC VOLUME, PATIENT-SPECIFIC DOSIMETRY AND THERAPEUTIC RESPONSE FOR PATIENTS TREATED USING RADIOIMMUNOTHERAPY (RIT)
Authors: SHEN S DENARDO GL YUAN A ODONNELL RT DENARDO SJ
Citation: S. Shen et al., SPLENIC VOLUME, PATIENT-SPECIFIC DOSIMETRY AND THERAPEUTIC RESPONSE FOR PATIENTS TREATED USING RADIOIMMUNOTHERAPY (RIT), The Journal of nuclear medicine, 39(5), 1998, pp. 839-839
PREVENTION OF RADIOLYSIS OF Y-90 IMMUNOCONJUGATES
Authors: KUKIS DL DENARDO SJ ODONNELL RT DENARDO GL
Citation: Dl. Kukis et al., PREVENTION OF RADIOLYSIS OF Y-90 IMMUNOCONJUGATES, The Journal of nuclear medicine, 39(5), 1998, pp. 1069-1069
SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY
Authors: DENARDO SJ RICHMAN CM KUKIS DL SHEN S LAMBORN KR MIERS LA KROGER LA DENARDO GL
Citation: Sj. Denardo et al., SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 1083-1083
PROLONGED SURVIVAL AND CYTOTOXIC - NHL SPECIFIC ANTIBODIES IN A PATIENT TREATED WITH I-131 LYM-1 MOUSE MONOCLONAL-ANTIBODY
Authors: DENARDO GL MIRICK GR ODONNELL RT KROGER LA MIERS LA DENARDO SJ
Citation: Gl. Denardo et al., PROLONGED SURVIVAL AND CYTOTOXIC - NHL SPECIFIC ANTIBODIES IN A PATIENT TREATED WITH I-131 LYM-1 MOUSE MONOCLONAL-ANTIBODY, The Journal of nuclear medicine, 39(5), 1998, pp. 1179-1179
YTTRIUM-90-DOTA-PEPTIDE CHIMERIC L6 RADIOIMMUNOCONJUGATE - EFFICACY AND TOXICITY IN MICE BEARING P53 MUTANT HUMAN BREAST-CANCER XENOGRAFTS
Authors: DENARDO SJ KUKIS DL MIERS LA WINTHROP MD KROGER LA SALAKO Q SHEN S LAMBORN KR GUMERLOCK PH MEARES CF DENARDO GL
Citation: Sj. Denardo et al., YTTRIUM-90-DOTA-PEPTIDE CHIMERIC L6 RADIOIMMUNOCONJUGATE - EFFICACY AND TOXICITY IN MICE BEARING P53 MUTANT HUMAN BREAST-CANCER XENOGRAFTS, The Journal of nuclear medicine, 39(5), 1998, pp. 842-849
EFFECTS OF RADIOLYSIS ON YTTRIUM-90-LABELED LYM-1 ANTIBODY PREPARATIONS
Authors: SALAKO QA ODONNELL RT DENARDO SJ
Citation: Qa. Salako et al., EFFECTS OF RADIOLYSIS ON YTTRIUM-90-LABELED LYM-1 ANTIBODY PREPARATIONS, The Journal of nuclear medicine, 39(4), 1998, pp. 667-670
TREATMENT-RELATED PARAMETERS PREDICTING EFFICACY OF LYM-1 RADIOIMMUNOTHERAPY IN PATIENTS WITH B-LYMPHOCYTIC MALIGNANCIES
Authors: LAMBORN KR DENARDO GL DENARDO SJ GOLDSTEIN DS SHEN S LARKIN EC KROGER LA
Citation: Kr. Lamborn et al., TREATMENT-RELATED PARAMETERS PREDICTING EFFICACY OF LYM-1 RADIOIMMUNOTHERAPY IN PATIENTS WITH B-LYMPHOCYTIC MALIGNANCIES, Clinical cancer research, 3(8), 1997, pp. 1253-1260
EFFICACY AND TOXICITY OF CU-67-2IT-BAT-LYM-1 RADIOIMMUNOCONJUGATE IN MICE IMPLANTED WITH HUMAN BURKITTS-LYMPHOMA (RAJI)
Authors: DENARDO GL KUKIS DL SHEN S MAUSNER LF MEARES CF SRIVASTAVA SC MIERS LA DENARDO SJ
Citation: Gl. Denardo et al., EFFICACY AND TOXICITY OF CU-67-2IT-BAT-LYM-1 RADIOIMMUNOCONJUGATE IN MICE IMPLANTED WITH HUMAN BURKITTS-LYMPHOMA (RAJI), Clinical cancer research, 3(1), 1997, pp. 71-79
DECREASED C-MYC AND BCL2 EXPRESSION CORRELATES WITH METHYLPREDNISOLONE-MEDIATED INHIBITION OF RAJI LYMPHOMA GROWTH
Authors: MORRIS G DENARDO SJ DENARDO GL LESHCHINSKY T WU BA MACK PC WINTHROP MD GUMERLOCK PH
Citation: G. Morris et al., DECREASED C-MYC AND BCL2 EXPRESSION CORRELATES WITH METHYLPREDNISOLONE-MEDIATED INHIBITION OF RAJI LYMPHOMA GROWTH, Biochemical and molecular medicine, 60(2), 1997, pp. 108-115
PRACTICAL DETERMINATION OF ORGAN S-VALUE FOR INDIVIDUAL PATIENTS FOR THERAPY
Authors: SHEN S DENARDO GL MACEY DJ ODONNELL RT YUAN A DENARDO DA DENARDO SJ
Citation: S. Shen et al., PRACTICAL DETERMINATION OF ORGAN S-VALUE FOR INDIVIDUAL PATIENTS FOR THERAPY, Nuclear medicine and biology, 24(5), 1997, pp. 447-449
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>